Literature DB >> 30772383

Patient characteristics affect hip contact forces during gait.

E De Pieri1, D E Lunn2, G J Chapman3, K P Rasmussen4, S J Ferguson5, A C Redmond6.   

Abstract

OBJECTIVE: To examine hip contact force (HCF), calculated through multibody modelling, in a large total hip replacement (THR) cohort stratified by patient characteristics such as body mass index (BMI), age and function.
METHOD: 132 THR patients undertook one motion capture session of gait analysis at a self-selected walking speed. HCFs were then calculated using the AnyBody Modelling System. Patients were stratified into three BMI groups, five age groups, and finally three functional groups determined by their self-selected gait speed. By means of statistical parametric mapping (SPM), statistical analyses of the 1-dimensional time series were performed to separately evaluate the influence of age, BMI and functionality on HCF.
RESULTS: The mean predicted HCFs were comparable to HCFs measured with instrumented prostheses reported in the literature. The SPM analysis revealed a statistically significant positive linear correlation between BMI and HCF, indicating that obese patients are more likely to experience higher HCF during most of the stance phase, while a statistically significant negative correlation with age was found only during the late swing-phase. Patients with higher functional ability exhibited significantly increased peak HCF, while patients with lower functional ability demonstrated lower HCFs overall and a pathological flattening of the typical double hump force profile.
CONCLUSION: HCFs experienced at the bearing surface are highly dependent on patient characteristics. BMI and functional ability were determined to have the biggest influence on contact forces. Current preclinical testing standards do not reflect this.
Copyright © 2019 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomechanics; Gait; Hip contact force; Stratification; Total hip replacement

Year:  2019        PMID: 30772383     DOI: 10.1016/j.joca.2019.01.016

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  7 in total

Review 1.  The Role of Lower-Limb Geometry in the Pathophysiology of Atypical Femoral Fracture.

Authors:  Ifaz T Haider; Prism S Schneider; W Brent Edwards
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

Review 2.  A review of musculoskeletal modelling of human locomotion.

Authors:  Adam D Sylvester; Steven G Lautzenheiser; Patricia Ann Kramer
Journal:  Interface Focus       Date:  2021-08-13       Impact factor: 4.661

Review 3.  Torsional deformities and overuse injuries: what does the literature tell us.

Authors:  Gherardo Pagliazzi; Enrico De Pieri; Michèle Kläusler; Morgan Sangeux; Elke Viehweger
Journal:  EFORT Open Rev       Date:  2022-01-11

4.  Relationship Between the Choice of Clinical Treatment, Gait Functionality and Kinetics in Patients With Comparable Knee Osteoarthritis.

Authors:  Simone Tassani; Laura Tio; Francisco Castro-Domínguez; Jordi Monfort; Juan Carlos Monllau; Miguel Angel González Ballester; Jérôme Noailly
Journal:  Front Bioeng Biotechnol       Date:  2022-03-11

5.  Altered Muscle Contributions are Required to Support the Stance Limb During Voluntary Toe-Walking.

Authors:  Enrico De Pieri; Jacqueline Romkes; Christian Wyss; Reinald Brunner; Elke Viehweger
Journal:  Front Bioeng Biotechnol       Date:  2022-04-11

6.  Increased Femoral Anteversion Does Not Lead to Increased Joint Forces During Gait in a Cohort of Adolescent Patients.

Authors:  Nathalie Alexander; Reinald Brunner; Johannes Cip; Elke Viehweger; Enrico De Pieri
Journal:  Front Bioeng Biotechnol       Date:  2022-06-06

7.  Effect of Unilateral Knee Extension Restriction on the Lumbar Region during Gait.

Authors:  Shintaro Nakatsuji; Masayuki Kawada; Yasufumi Takeshita; Yuta Matsuzawa; Kazutaka Hata; Sota Araki; Ryoji Kiyama
Journal:  J Healthc Eng       Date:  2022-08-22       Impact factor: 3.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.